Diasorin acquisition of luminex
WebJul 14, 2024 · Saluggia, July 14, 2024 - DiaSorin S.p.A. (" DiaSorin "; FTSE MIB: DIA) announces it has completed the. acquisition of Luminex Corporation (" Luminex "; NASDAQ: LMNX) for a price of USD 37.00 per share that corresponds to a total equity value of approximately USD 1.8 billion. Through the acquisition, DiaSorin will gain access to … WebApr 12, 2024 · Yesterday’s debt-fuelled purchase of Luminex by Diasorin is, at $1.8bn, tied with Roche’s takeout of Genmark Diagnostics as the biggest acquisition of a Covid-19 test developer so far this year. But the buyers also have suites of Covid-19 assays of their own. Drowning in cash as a result, the big guns have their pick of acquisition targets ...
Diasorin acquisition of luminex
Did you know?
WebApr 12, 2024 · April 12, 2024— DiaSorin has signed a definitive merger agreement to acquire Luminex for a total equity value of about $1.8 billion. Luminex, headquartered in Austin, Tex., develops, manufactures, and sells proprietary biological testing technologies and products throughout the diagnostics and life science industries. Through the … WebThe acquisition of Luminex Corporation represents an important step in the expansion strategy of DiaSorin ... DiaSorin Molecular LLC, a division of DiaSorin S.p.A., has received the Emergency Use Authorization (EUA) from the FDA for their Simplexa™ COVID-19 Direct kit. The kit provides a sample-to-answer test for the detection of severe acute ...
WebApr 12, 2024 · Through the acquisition, DiaSorin will gain access to Luminex’s molecular diagnostics multiplexing technology and a portfolio that will strengthen its existing offering while expanding its ... Web6.6 DiaSorin 6.6.1 DiaSorin Corporation Information 6.6.2 DiaSorin Description and Business Overview 6.6.3 DiaSorin Electrochemiluminescent Immunoassay Analyzer Sales, Revenue and Gross Margin (2024-2024) 6.6.4 DiaSorin Electrochemiluminescent Immunoassay Analyzer Product Portfolio 6.6.5 DiaSorin Recent Developments/Updates …
WebDiaSorin's acquisition of Luminex Corporation represents an essential step in our global expansion strategy. Today, we begin a new phase of … WebIn a statement, DiaSorin noted that the acquisition of Luminex also attributed to overall revenue growth, while a decline in COVID-19-related revenues offset growth. Immunodiagnostic revenues, excluding COVID, grew about 8 percent year over year on the strength of CLIA testing revenues despite a drop in vitamin D and ELISA panel testing …
WebJul 14, 2024 · “The acquisition of Luminex represents an important step in the expansion strategy of DiaSorin. Today, we begin a new phase of our growth, that will position DiaSorin as a fully-fledged diagnostic and life science player, that can offer increasingly … Luminex. 1224 Deming Way Madison, WI 53717. Phone: +1 608 662 9000. Toll … DiaSorin was born in 2000 from an entrepreneurial intuition of our … Presentation - DiaSorin to acquire Luminex Corporation. pdf download presentation … DiaSorin S.p.A. - Share Capital €55.948.257 R.E.A. 180729 Fiscal Code … DiaSorin Culture and Leadership style are key differentiating factors for our Talent …
WebApr 12, 2024 · Fionna Agomuoh. Apr 12, 2024 11:13 AM EDT. Luminex ( LMNX) - Get Free Report definitively agreed to be acquired by the Italian diagnostics company DiaSorin DSRLF for $37 a share cash, or $1.8 ... daniel thomas law yanceyville ncWebJul 9, 2024 · Home / Investors / Financial corner / Press releases / DiaSorin obtains all approvals necessary to complete the acquisition of Luminex. DiaSorin obtains all approvals necessary to complete the acquisition of Luminex. Fri, 07/09/2024 - 07:34. pdf ... DiaSorin S.p.A. - Share Capital €55.948.257 R.E.A. 180729 Fiscal Code and … daniel thomas barnet councilWebApr 12, 2024 · The acquisition will broaden DiaSorin’s positioning in the molecular diagnostics space gaining access to Luminex’s molecular diagnostics multiplexing … daniel thomas huk coburgWebFeb 13, 2024 · Acquisition will expand Cytek’s product portfolio to include imaging and menu-based application driven flow cytometry to provide full cell analysis solutions to its customers; transaction is in line with DiaSorin’s strategic priorities communicated to the market after Luminex acquisition daniel thomas lake mary floridaWebThe strengthening of DiaSorin's role as a diagnostic specialist and a global player was a significant input towards the Luminex acquisition, a leading company in the fields of multiplexing molecular diagnostics and Life Science. ... This new business area resulting from the Luminex acquisition supports DiaSorin’s access to scientific research ... birthday appreciation giftsWebFeb 25, 2024 · Italian diagnostics company DiaSorin SpA is considering an acquisition of rival Covid-19 testing-kit maker Luminex Corp., according to people familiar with the … daniel thomas nixWebAbout. As President, Chief Executive Officer, and Chairman of Luminex Corporation, it is my mission to empower laboratories to obtain reliable, timely, and actionable answers, ultimately advancing ... daniel thomas mcdowell sheriff